Akanda Corp. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by HRT FINANCIAL LP, was filed 20 Jan 2026.
Akanda Corp.: what insiders have been doing
Akanda Corp. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Between 10 November 2025 and 10 November 2026, 1 insider published 2 filings.
Both sides are active: 1 purchase worth €35k and 1 sale worth €8,743, from 1 insider and 1 insider respectively. Netting one side against the other leaves €26k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 major shareholder. HRT Financial LP filed the largest purchase, €35k, on 20 January 2026.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 2 filings, this issuer sits below that mark. The full history, which starts in 2026, counts 1 purchase against 1 sale.
The last purchase on record was published on 20 January 2026, which is 294 days ago.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -49.9%Entry US$6.49 · Close at T+90 US$3.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 29,036 shares@ US$1.4080.0% of flowClass A SharesSEC:0001475597-26-000002:0Canonical exit: 15 Apr 2026 (T+90)
- 7,868 shares@ US$1.2920.0% of flowClass A SharesSEC:0001475597-26-000002:1
2 of 2 declarations
About Akanda Corp.
Akanda Corp. is a company listed on the XNAS market. It specializes in the health and pharmaceutical sector.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
